Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02332161 · ClinicalTrials.gov registry record

Leg Function and ADL After ALT Reconstruction for Head and Neck Cancer

A clinical trial, sponsored by University of Chicago.

Completed
Registry status
8
Enrollment target

NCT02332161 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 8 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02332161 has completed, sponsored by University of Chicago.

COMPLETED
Registry status
8 participants
Enrollment target

Study Summary

Anterolateral thigh (ALT) free flap tissue transfer is a commonly used method of head and neck reconstruction after head and neck cancer removal. The procedure involves removing some muscle, skin, and tissue from the thigh, and this may affect leg function. The purpose of this study is to determine the impact of ALT on ambulation and activities of daily living (ADLs)

Interventions

  • OTHER surveys, evaluative tests for leg function

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2014-01
Est. Completion 2017-06-26

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT02332161

The ClinicalTrials.gov registry entry for NCT02332161 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which surveys, evaluative tests for leg function is the first listed.

NCT02332161 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02332161 about?

NCT02332161 is a clinical study titled "Leg Function and ADL After ALT Reconstruction for Head and Neck Cancer". Anterolateral thigh (ALT) free flap tissue transfer is a commonly used method of head and neck reconstruction after head and neck cancer removal. The procedure involves removing some muscle, skin, and tissue from the thigh, and this may affect leg function. The purpose of this study is to determine ...

What is the current status of trial NCT02332161?

This trial is currently completed. The enrollment target is 8 participants. The study started on 2014-01. Estimated completion is 2017-06-26.

What interventions are being tested in trial NCT02332161?

The interventions under investigation include: surveys, evaluative tests for leg function (OTHER).

Who is sponsoring clinical trial NCT02332161?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.